Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 12/20 | 0.42 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 4/20 | 0.34 |
| ▸ | IDH2 | P48735 | 3/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31489526 | 1.00 | CREBBP (0.42) | CREBBPGPR55CYP17A1IDH1IDH2 | |
| SCHEMBL31489258 | 0.85 | CREBBP (0.42) | CREBBPGPR55CYP17A1BRD4 | |
| SCHEMBL31489347 | 0.85 | CREBBP (0.42) | CREBBPGPR55CYP17A1BRD4 | |
| SCHEMBL31489699 | 0.79 | CREBBP (0.39) | CREBBPGPR55CYP17A1BRD4 | |
| SCHEMBL31489770 | 0.79 | CREBBP (0.39) | CREBBPGPR55CYP17A1BRD4 | |
| SCHEMBL31489216 | 0.75 | CREBBP (0.45) | CREBBPGPR55CYP17A1BRD4 | |
| SCHEMBL31489380 | 0.75 | CREBBP (0.40) | CREBBPGPR55CYP17A1 | |
| SCHEMBL31489577 | 0.75 | CREBBP (0.45) | CREBBPGPR55CYP17A1BRD4 | |
| SCHEMBL31489470 | 0.75 | CREBBP (0.40) | CREBBPGPR55CYP17A1 | |
| SCHEMBL18097819 | 0.71 | PDE2A (0.48) | CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072395-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-03 | — | — | WO | disclosed |